Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| naive B cell | 9 studies | 23% ± 6% | |
| glutamatergic neuron | 4 studies | 43% ± 14% | |
| interneuron | 4 studies | 37% ± 22% | |
| B cell | 3 studies | 17% ± 2% | |
| GABAergic neuron | 3 studies | 42% ± 9% | |
| astrocyte | 3 studies | 34% ± 3% | |
| oligodendrocyte | 3 studies | 24% ± 1% | |
| oligodendrocyte precursor cell | 3 studies | 35% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 34% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2320.57 | 1445 / 1445 | 100% | 24.29 | 183 / 183 |
| intestine | 100% | 2821.29 | 966 / 966 | 100% | 14.38 | 525 / 527 |
| stomach | 100% | 1777.35 | 358 / 359 | 100% | 16.39 | 285 / 286 |
| breast | 100% | 2812.24 | 459 / 459 | 99% | 16.93 | 1110 / 1118 |
| lung | 100% | 2561.00 | 578 / 578 | 99% | 14.53 | 1140 / 1155 |
| skin | 100% | 2855.76 | 1809 / 1809 | 98% | 18.59 | 464 / 472 |
| thymus | 100% | 4098.57 | 653 / 653 | 98% | 12.93 | 594 / 605 |
| ovary | 100% | 3647.62 | 180 / 180 | 98% | 11.47 | 421 / 430 |
| brain | 98% | 1905.43 | 2586 / 2642 | 100% | 15.37 | 704 / 705 |
| bladder | 100% | 2722.00 | 21 / 21 | 97% | 10.96 | 490 / 504 |
| uterus | 100% | 4211.98 | 170 / 170 | 97% | 12.01 | 446 / 459 |
| pancreas | 99% | 1611.64 | 326 / 328 | 98% | 9.49 | 174 / 178 |
| prostate | 100% | 3139.44 | 245 / 245 | 97% | 10.43 | 487 / 502 |
| adrenal gland | 100% | 2232.64 | 257 / 258 | 92% | 7.42 | 212 / 230 |
| kidney | 100% | 1793.74 | 89 / 89 | 91% | 9.66 | 818 / 901 |
| liver | 99% | 1440.83 | 224 / 226 | 88% | 8.11 | 358 / 406 |
| adipose | 100% | 2599.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2713.07 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 15.77 | 29 / 29 |
| spleen | 100% | 3946.22 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.29 | 1 / 1 |
| muscle | 99% | 1667.80 | 796 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 15.66 | 44 / 45 |
| heart | 97% | 1513.39 | 834 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 9.27 | 76 / 80 |
| peripheral blood | 85% | 5474.98 | 786 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051321 | Biological process | meiotic cell cycle |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0003676 | Molecular function | nucleic acid binding |
| Gene name | ZNF318 |
| Protein name | Zinc finger protein 318 (Endocrine regulatory protein) Zinc finger protein 318 |
| Synonyms | HRIHFB2436 |
| Description | FUNCTION: [Isoform 2]: Acts as a transcriptional corepressor for AR-mediated transactivation function. May act as a transcriptional regulator during spermatogenesis and, in particular, during meiotic division. .; FUNCTION: [Isoform 1]: Acts as a transcriptional coactivator for AR-mediated transactivation function. May act as a transcriptional regulator during spermatogenesis and, in particular, during meiotic division. . |
| Accessions | ENST00000606599.1 Q5VUA4 ENST00000361428.3 [Q5VUA4-1] U3KQ37 ENST00000605935.5 [Q5VUA4-2] |
